WO2009152167A3 - Delivery of therapeutics - Google Patents

Delivery of therapeutics Download PDF

Info

Publication number
WO2009152167A3
WO2009152167A3 PCT/US2009/046773 US2009046773W WO2009152167A3 WO 2009152167 A3 WO2009152167 A3 WO 2009152167A3 US 2009046773 W US2009046773 W US 2009046773W WO 2009152167 A3 WO2009152167 A3 WO 2009152167A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutics
delivery
methods
devices
present
Prior art date
Application number
PCT/US2009/046773
Other languages
French (fr)
Other versions
WO2009152167A2 (en
Inventor
Dean Ho
Robert Lam
Mark Chen
Houjin Huang
Erik Pierstorff
Erik Robinson
Original Assignee
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwestern University filed Critical Northwestern University
Publication of WO2009152167A2 publication Critical patent/WO2009152167A2/en
Publication of WO2009152167A3 publication Critical patent/WO2009152167A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A61L2300/222—Steroids, e.g. corticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624—Nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Abstract

The present invention provides materials and devices for the controlled release of therapeutics, and methods for uses thereof.
PCT/US2009/046773 2008-06-09 2009-06-09 Delivery of therapeutics WO2009152167A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5997608P 2008-06-09 2008-06-09
US5997908P 2008-06-09 2008-06-09
US61/059,976 2008-06-09
US61/059,979 2008-06-09

Publications (2)

Publication Number Publication Date
WO2009152167A2 WO2009152167A2 (en) 2009-12-17
WO2009152167A3 true WO2009152167A3 (en) 2010-05-14

Family

ID=41417375

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/046773 WO2009152167A2 (en) 2008-06-09 2009-06-09 Delivery of therapeutics

Country Status (2)

Country Link
US (1) US20100040672A1 (en)
WO (1) WO2009152167A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10799593B2 (en) 2008-06-09 2020-10-13 Northwestern University Nanodiamond particle complexes
CA2766912A1 (en) * 2009-05-28 2010-12-02 Northwestern University Nanodiamond particle complexes
CA2879407A1 (en) * 2012-07-18 2014-01-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of preparing silica-coated nanodiamonds
US9049805B2 (en) 2012-08-30 2015-06-02 Lockheed Martin Corporation Thermally-conductive particles in printed wiring boards
DE102012023348B4 (en) * 2012-11-29 2016-09-29 Hochschule München Method for testing an active substance depot by means of an imaging method
WO2016062764A1 (en) * 2014-10-23 2016-04-28 Biotronik Se & Co. Kg Method for treating a medical implant
US9616022B1 (en) * 2016-07-07 2017-04-11 The Florida International University Board Of Trustees Nanodiamond compositions and their use for drug delivery
WO2023034056A1 (en) * 2021-09-03 2023-03-09 Bionaut Labs Ltd. Hydrogel-matrix encapsulated oligonucleotides and methods for formulating and using encapsulated oligonucleotides

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220829A1 (en) * 2004-03-30 2005-10-06 Chien-Min Sung Healthcare and cosmetic compositions containing nanodiamond
US20050281858A1 (en) * 2004-06-18 2005-12-22 Kloke Tim M Devices, articles, coatings, and methods for controlled active agent release
US20060051401A1 (en) * 2004-09-07 2006-03-09 Board Of Regents, The University Of Texas System Controlled nanofiber seeding
WO2008022258A2 (en) * 2006-08-16 2008-02-21 Surmodics, Inc. Methods and materials for increasing the adhesion of elution control matrices to substrates
US20090004241A1 (en) * 2007-06-08 2009-01-01 Northwestern University Polymer nanofilm coatings

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
DE2437629C3 (en) * 1974-08-05 1978-09-21 Basf Ag, 6700 Ludwigshafen Process for the preparation of insoluble polymers of N-vinyllactams which are only slightly swellable in water
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US5460830A (en) * 1990-06-22 1995-10-24 The Regents Of The University Of California Biochemically active agents for chemical catalysis and cell receptor activation
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
AU2001264623A1 (en) * 2000-05-16 2001-11-26 Biocure, Inc. Membranes formed from amphiphilic copolymers
US20060222756A1 (en) * 2000-09-29 2006-10-05 Cordis Corporation Medical devices, drug coatings and methods of maintaining the drug coatings thereon
DE10125599A1 (en) * 2001-05-25 2002-11-28 Stockhausen Chem Fab Gmbh Super-absorbent polymer powder for use in e.g. diapers, packaging and soil improvers, obtained by pre-swelling polycarboxy-polysaccharide in water and then drying and surface-crosslinking resulting hydrogel
US7828728B2 (en) * 2003-07-25 2010-11-09 Dexcom, Inc. Analyte sensor
KR20040097126A (en) * 2002-02-15 2004-11-17 씨브이 쎄러퓨틱스, 인코포레이티드 Polymer coating for medical devices
EP1493015A4 (en) * 2002-04-05 2006-01-04 Powerzyme Inc Analyte sensor
US7329414B2 (en) * 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
EP1549689B1 (en) * 2002-10-02 2010-05-26 Coloplast A/S A hydrogel
US7173655B2 (en) * 2002-10-18 2007-02-06 Hewlett-Packard Development Company, L.P. Capture of sensory data in association with digital still images
US7459169B2 (en) * 2002-10-21 2008-12-02 Allvivo, Inc. Surface coating comprising bioactive compound
WO2004060967A1 (en) * 2002-12-31 2004-07-22 Nektar Therapeutics Al, Corporation Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
US7820130B2 (en) * 2003-11-26 2010-10-26 William Marsh Rice University Functionalization of nanodiamond powder through fluorination and subsequent derivatization reactions
US7211108B2 (en) * 2004-01-23 2007-05-01 Icon Medical Corp. Vascular grafts with amphiphilic block copolymer coatings
US20060088571A1 (en) * 2004-10-21 2006-04-27 Medtronic Vascular, Inc. Biocompatible and hemocompatible polymer compositions
US20070259101A1 (en) * 2006-05-02 2007-11-08 Kleiner Lothar W Microporous coating on medical devices
WO2008039749A2 (en) * 2006-09-25 2008-04-03 Surmodics, Inc. Multi-layered coatings and methods for controlling elution of active agents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220829A1 (en) * 2004-03-30 2005-10-06 Chien-Min Sung Healthcare and cosmetic compositions containing nanodiamond
US20050281858A1 (en) * 2004-06-18 2005-12-22 Kloke Tim M Devices, articles, coatings, and methods for controlled active agent release
US20060051401A1 (en) * 2004-09-07 2006-03-09 Board Of Regents, The University Of Texas System Controlled nanofiber seeding
WO2008022258A2 (en) * 2006-08-16 2008-02-21 Surmodics, Inc. Methods and materials for increasing the adhesion of elution control matrices to substrates
US20090004241A1 (en) * 2007-06-08 2009-01-01 Northwestern University Polymer nanofilm coatings

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EDWARD KAI-HUA CHOW ET AL.: "Copolymeric nanofilm platform for controlled and localized therapeutic delivery.", ACSNANO., vol. 2, no. 1, 22 December 2007 (2007-12-22), pages 33 - 40 *
HUANG HOUJIN ET AL.: "Active nanodiamond hydrogels for chemotherapeutic delivery", NANO LETTERS, vol. 7, no. 11, 5 October 2007 (2007-10-05), pages 3305 - 3314 *
HUANG HOUJIN ET AL.: "Protein-mediated assembly of nanodiamond hydrogels into a biocmpatible and biofunctional multilayer nanofilm.", ASCNANO., vol. 2, no. 2, 1 February 2008 (2008-02-01), pages 203 - 212 *
ROBERT LAM ET AL.: "Nanodiamond-embedded microfilm devices for localized chemotherapeutic elution", ACSNANO, vol. 2, no. 10, 2 October 2008 (2008-10-02), pages 2095 - 2102 *

Also Published As

Publication number Publication date
WO2009152167A2 (en) 2009-12-17
US20100040672A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
HRP20181353T1 (en) The tuberculosis rv2386c protein, compositions and uses thereof
WO2011142858A3 (en) Chlorotoxin variants, conjugates, and methods for their use
WO2011031896A3 (en) Pi3 kinase inhibitors and uses thereof
UA104459C2 (en) Anti-fgfr3 antibodies and methods using same
WO2012076293A9 (en) Formulations comprising polysiloxanes having nitrogen-containing groups
IL220625A (en) Isoindolinone compounds, compositions comprising the same and uses thereof
WO2012024526A3 (en) Conjugates, particles, compositions, and related methods
AP2010005387A0 (en) Use of defensins against tuberculosis.
WO2009152167A3 (en) Delivery of therapeutics
WO2011072099A3 (en) Compositions and methods comprising protease variants
MX2012007507A (en) Heteroaryl compounds and uses thereof.
IL206148A0 (en) Polymeric composition, method for the manufacture of the polymeric composition, articles based on this polymeric composition and use of these articles
WO2009067674A3 (en) Polymorphs of sunitinib base and processes for preparation thereof
WO2009130479A3 (en) Virus
WO2011133504A3 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
ZA201005278B (en) Folates, compositions and uses thereof
EP2527404A4 (en) Composition for ultraviolet ray-absorbable member, and ultraviolet ray-absorbable member comprising same
WO2011075636A3 (en) Wise binding agents and epitopes
WO2009120380A3 (en) Recombinant rhinovirus vectors
WO2012145680A3 (en) Anti-microbial peptides and uses therefore
EP2643044A4 (en) Biliary shunts, delivery systems, and methods of using the same
EP2298082A4 (en) Composition for feed, and feed comprising the same
WO2009005718A8 (en) Polypeptide microparticles having sustained release characteristics, methods and uses
WO2012024350A3 (en) Anti-cancer adenoviruses
WO2011050188A8 (en) Anti-hepsin antibodies and methods using same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09763457

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09763457

Country of ref document: EP

Kind code of ref document: A2